Effects of naloxone on myocardial ischemic preconditioning in humans

Journal of the American College of Cardiology

Volumn 33, Issue 7, 1999, Pages 1863-1869

  Tomai, Fabrizio ^a   Crea, Filippo ^b   Gaspardone, Achille ^a   Versaci, Francesco ^a   Ghini, Anna S ^a   Ferri, Claudio ^c   Desideri, Giovambattista ^c   Chiariello, Luigi ^a   Gioffré, Pier A ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NALOXONE; OPIATE RECEPTOR;

ADAPTATION; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLATERAL CIRCULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION PREVENTION; HEART MUSCLE ISCHEMIA; HUMAN; MALE; NOCICEPTION; PRIORITY JOURNAL; SCORING SYSTEM; ST SEGMENT ELEVATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD FLOW VELOCITY; CHEST PAIN; COLLATERAL CIRCULATION; CORONARY VESSELS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; RECEPTORS, OPIOID; SINGLE-BLIND METHOD; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 0032739515     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00095-9     Document Type: Article

References (54)

1. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia a delay of lethal cell injury in ischemic myocardium . Circulation. 74:1986;1124-1136.
2. Schott R.J., Rohmann S., Braun E.R., Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res. 66:1990;1133-1142.
3. Cohen M.V., Liu G.S., Downey J.M. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 84:1991;341-349.
4. Li Y.W., Whittaker P., Kloner R.A. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmias. Am Heart J. 123:1992;346-353.
5. Ikonomidis J.S., Tumiati L.C., Weisel R.D., et al. Preconditioning human ventricular cardiomyocytes with brief periods of simulated ischaemia. Cardiovasc Res. 28:1994;1285-1291.
6. Walker D.M., Walker J.M., Pugsley W.B., et al. Preconditioning in isolated superfused human muscle. J Mol Cell Cardiol. 27:1995;1349-1357.
7. Deutsch E., Berger M., Kussmaul W.G., et al. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation. 82:1990;2044-2051.
8. Tomai F., Crea F., Gaspardone A., et al. Mechanisms of cardiac pain during coronary angioplasty. J Am Coll Cardiol. 22:1993;1892-1896.
9. Yellon D.M., Alkhulaifi A.M., Pugsley W.B. Preconditioning the human myocardium. Lancet. 342:1993;276-277.
10. Kloner R.A., Shook T., Przyklenk K., et al. Previous angina alters in hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation. 91:1995;37-47.
11. Lawson C.S., Downey J.M. Preconditioning state of the art myocardial protection . Cardiovasc Res. 27:1993;542-550.
12. Downey J.M., Cohen M.V. Mechanisms of preconditioning correlates and epiphenomena . Marber M.S., Yellon D.M. Ischaemia Preconditioning and Adaptation . 1996;21-34 UCL Molecular Pathology Series, BIOS Scientific Publishers Ld, Oxford, U.K.
13. 1 adenosine receptor blockade by bamiphylline on ischaemic preconditioning during coronary angioplasty. Eur Heart J. 17:1996;846-853.
14. Leesar M.A., Stoddard M., Ahmed M., et al. Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation. 95:1997;2500-2507.
15. Tomai F., Crea F., Gaspardone A., et al. Phentolamine prevents adaptation to ischemia during coronary angioplasty. Role of α-adrenergic receptors in ischemic preconditioning. Circulation. 96:1997;2171-2177.
16. + channel blocker. Circulation. 90:1994;700-705.
17. Schultz J.J., Rose E., Yao Z., Gross G.J. Evidence for involvement of opioid receptors in ischemic preconditioning in rat hearts. Am J Physiol. 268:1995;H2157-H2161.
18. Schultz J.J., Hsu A.K., Gross G.J. Morphine mimics the cardioprotective effect of ischemic preconditioning via a glibenclamide-sensitive mechanism in the rat heart. Circ Res. 78:1996;1100-1104.
19. Chien G.L., Van Winkle D.M. Naloxone blockade of myocardial ischemic preconditioning is stereoselective. J Mol Cell Cardiol. 28:1996;1895-1900.
20. Schultz J.J., Hsu A.K., Gross G.J. Ischemic preconditioning is mediated by a peripheral opioid receptor mechanism in the intact rat heart. J Mol Cell Cardiol. 29:1997;1355-1362.
21. Schultz J.J., Hsu A.K., Gross G.J. Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol. 29:1997;2187-2195.
22. 1- but not μ- or κ-opioid receptors. Circulation. 97:1998;1282-1289.
23. 2-agonists in locus coeruleus neurons. Brain Res. 371:1986;390-394.
24. Burns D.L., Hewlett E.L., Moss J., Vaughan M. Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108-15 cells. J Biol Chem. 258:1983;1435-1438.
25. North R.A. Opioid actions on membrane ion channels. Herz A. Handbook of Pharmacology Opioids I . 1993;774-797 Springer-Verlag, New York.
26. Mangoura D., Dawson G. Opioid peptides activate phospholipase D and protein kinase C-ε in chicken embryo neuron cultures. Proc Natl Acad Sci USA. 90:1993;2915-2919.
27. + channels. Am J Physiol. 269:1995;H997-H1002.
28. Jaffe J.H., Martin W.R. Opioid analgesics and antagonists. Goodman L.S., Gilman A., Rall T.W., Nies A.S., Taylor P. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 8th ed. 1990;485-521 McGraw-Hill, New York.
29. Rentrop K.P., Cohen M., Blanke H., Phillips R. Changes in collateral filling immediately following controlled coronary artery occlusion by an angioplasty balloon in man. J Am Coll Cardiol. 5:1985;587-592.
30. Tomai F., Crea F., Gaspardone A., et al. Determinants of myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with significant narrowing of a single coronary artery and stable or unstable angina pectoris. Am J Cardiol. 74:1994;1089-1094.
31. Kern M.J., Donohue T.J., Bach R.G., et al. Quantitating coronary collateral flow velocity in patients during coronary angioplasty using a Doppler guidewire. Am J Cardiol. 71:1993;34D-40D.
32. Piek J.J., Koolen J.J., Metting van Rijn A.C., et al. Spectral analysis of flow velocity in the contralateral artery during coronary angioplasty a new method for assessing collateral flow . J Am Coll Cardiol. 21:1993;1574-1582.
33. Kyriakidis M.K., Petropoulakis P.N., Tentolouris C.A., et al. Relation between changes in blood flow of the contralateral coronary artery and the angiographic extent and function of recruitable collateral vessels arising from this artery during balloon coronary occlusion. J Am Coll Cardiol. 23:1994;869-878.
34. Reiber J.H.C. On-line quantification of coronary angiograms with the DCI system. Medica Mundi. 34:1989;89-98.
35. Tomai F. Ischaemic preconditioning during coronary angioplasty. Marber M.S., Yellon D.M. Ischaemia Preconditioning and Adaptation . 1996;163-185 UCL Molecular Pathology Series, BIOS Scientific Publishers Ld, Oxford, U.K.
36. Marchant B., Umachandran V., Wilkinson P., et al. Reexamination of the role of endogenous opiates in silent myocardial ischemia. J Am Coll Cardiol. 23:1994;645-651.
37. Oldroyd K.G., Gray C.E., Carter R., et al. Activation and inhibition of the endogenous opioid system in human heart failure. Br Heart J. 73:1995;41-48.
38. Wallbridge D.R., MacIntyre H.E., Gray C.E., et al. Role of endogenous opioids and catecholamines in vasovagal syncope. Eur Heart J. 17:1996;1729-1736.
39. Huskisson E.C. Measurement of pain. Lancet. 2:1974;1127-1131.
40. Doucette J.W., Corl P.D., Payne H.M., et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation. 85:1992;1899-1911.
41. Segal J., Kern M.J., Scott N.A., et al. Alterations of phasic coronary artery flow velocity in humans during percutaneous coronary angioplasty. J Am Coll Cardiol. 20:1992;276-286.
42. Xenopoulos N.P., Leesar M., Bolli R. Morphine mimics ischemic preconditioning in human myocardium during PTCA (abstr). J Am Coll Cardiol. 31:(Suppl A):1998;65A.
43. Martin W.R. Pharmacology of opioids. Pharmacol Rev. 35:1984;283-323.
44. Russell J., Bass P., Goldberg L.I., et al. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists. Eur J Pharmacol. 78:1982;255-261.
45. Milne R.J., Coddington J.M., Gamble G.D. Quaternary naloxone blocks morphine analgesia in spinal but not intact rats. Neurosci Lett. 114:1990;259-264.
46. Ocana M., Del Pozo E., Barrios M., et al. An ATP-dependent potassium channel blocker antagonizes morphine analgesia. Eur J Pharmacol. 186:1990;377-378.
47. Welch S.P., Dunlow L.D. Antinociception activity of intrathecally administered potassium channel openers and opioid agonists a common mechanism of action? J Pharmacol Exp Ther. 267:1993;390-399.
48. + channel-acting drugs. Br J Pharmacol. 114:1995;1296-1302.
49. Raffa R.B., Martinez R.P. The "glibenclamide-shift" of centrally-acting antinociceptive agents in mice. Brain Res. 67:1995;277-282.
50. Ellestad M.H., Kuan P. Naloxone and asymptomatic ischemia failure to induce angina during exercise testing . Am J Cardiol. 54:1984;982-984.
51. Weidinger F., Hammerle A., Sochor H., et al. Role of beta-endorphins in silent myocardial ischemia. Am J Cardiol. 58:1986;428-430.
52. Cribier A., Korsatz L., Koning R., et al. Improved myocardial ischemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty a prospective study . J Am Coll Cardiol. 20:1992;578-586.
53. Shattock M.J., Lawson C.S., Hearse D.J., Downey J.M. Electrophysiological characteristics of repetitive ischemic preconditioning in the pig heart. J Mol Cell Cardiol. 28:1996;1339-1347.
54. Cohen M.V., Yang X.M., Downey J.M. Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon. Basic Res Cardiol. 92:1997;426-434.